Precision Biosciences (DTIL) Enterprise Value (2018 - 2026)
Precision Biosciences (DTIL) reported Enterprise Value of -$101.2 million for Q1 2026, down 31.03% year-over-year from -$146.7 million in Q1 2025, and up 12.46% quarter-over-quarter from -$115.6 million in Q4 2025.
Precision Biosciences (DTIL) Enterprise Value (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of Enterprise Value data on file, last reported at -$101.2 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$101.2 million, down 31.03% year-over-year; the trailing twelve-month figure through Mar 2026 was -$101.2 million (down 31.03% YoY), and the FY2025 annual result was -$115.6 million, down 33.92% from the prior year.
- Enterprise Value advanced to -$101.2 million in Q1 2026 per DTIL's latest filing, from -$115.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$44.9 million in Q3 2025 and troughed at -$212.1 million in Q3 2022.
- A 5-year average of -$122.8 million and a median of -$116.7 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value tumbled 36.06% in 2023, then surged 55.66% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$189.6 million in 2022, then surged by 38.45% to -$116.7 million in 2023, then climbed by 26.03% to -$86.3 million in 2024, then plunged by 33.92% to -$115.6 million in 2025, then grew by 12.46% to -$101.2 million in 2026.
- Business Quant data shows DTIL's Enterprise Value at -$101.2 million in Q1 2026, -$115.6 million in Q4 2025, and -$44.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -584.73 Mn |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - | -101.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -101.18 Mn |
| Dec 31, 2025 | -115.59 Mn |
| Sep 30, 2025 | -44.87 Mn |
| Jun 30, 2025 | -62.24 Mn |
| Mar 31, 2025 | -77.22 Mn |
| Dec 31, 2024 | -86.31 Mn |
| Sep 30, 2024 | -101.20 Mn |
| Jun 30, 2024 | -123.57 Mn |
| Mar 31, 2024 | -137.77 Mn |
| Dec 31, 2023 | -116.68 Mn |
| Sep 30, 2023 | -122.23 Mn |
| Jun 30, 2023 | -137.79 Mn |
| Mar 31, 2023 | -158.13 Mn |
| Dec 31, 2022 | -189.58 Mn |
| Sep 30, 2022 | -212.05 Mn |
| Jun 30, 2022 | -184.14 Mn |
| Mar 31, 2022 | -116.22 Mn |
| Dec 31, 2021 | -143.66 Mn |
| Sep 30, 2021 | -160.47 Mn |
| Jun 30, 2021 | -173.94 Mn |